MetaCap

Achieve Life Sciences Financial Statements

NASDAQ: QUITHealth CareBiotechnology: In Vitro & In Vivo Diagnostic SubstancesUSD

5.56-0.31 (-5.28%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Achieve Life Sciences revenue and earnings

Achieve Life Sciences reported a net loss of $54.6 million, compared with a loss of $39.8 million a year earlier. Diluted earnings per share came in at -$1.25.

Summary generated from market data by MetaCap's automated system. Methodology

Achieve Life Sciences income statement (annual)

Achieve Life Sciences annual income statement
Fiscal year (USD)FY 20252025-12-31FY 20242024-12-31FY 20232023-12-31FY 20222022-12-31FY 20212021-12-31FY 20202020-12-31FY 20192019-12-31FY 20182018-12-31FY 20172017-12-31FY 20162016-12-31
Revenue——————00——
Revenue growth (YoY)——————————
Research & Development—22.82M15.81M30.08M23.97M6.88M9.67M5.87M3.10M286.00K
Interest Expense819.00K2.18M2.85M1.79M——————
Other Income (Expense)232.00K-758.00K-2.56M-1.55M-58.00K20.00K133.00K126.00K-7.00M-24.00K
Pretax Income-54.65M-39.83M-29.82M-42.35M-33.15M-14.73M-16.39M-12.69M-13.63M-1.74M
Income Tax—————————0
Net Income-54.65M-39.83M-29.82M-42.35M-33.15M-14.73M-16.39M-12.69M-10.58M-1.23M
Net Income growth (YoY)——————————
EPS (Basic)-1.25-1.24-1.50-4.00-4.08-5.42-39.76-72.29-22.07-581.25
EPS (Diluted)-1.25-1.24-1.50-4.00-4.08-5.42-39.76-72.29-22.07-581.25
Shares Outstanding (Basic)43.59M32.07M19.83M10.59M8.12M2.72M412.32K175.51K479.44K2.12K
Shares Outstanding (Diluted)43.59M32.07M19.83M10.59M8.12M2.72M412.32K175.51K479.44K2.12K

This table shows 10 annual periods of Achieve Life Sciences's income statement, from FY 2025 back to FY 2016, across 12 line items including revenue, operating expenses, research & development. Values in USD; B = billions, M = millions. Fiscal periods follow QUIT's reporting calendar. What is a income statement?

More financial data